Title |
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study |
|---|---|
Involved |
Michael Lehrke (Verfasser)
Anja Vogt (Verfasser) Volker Schettler (Verfasser) Matthias Girndt (Verfasser)
Uwe Fraass (Verfasser)
Anja Tabbert-Zitzler (Verfasser) Ian Bridges (Verfasser) Nafeesa N. Dhalwani (Verfasser) Kausik K. Ray (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Advances in therapy 41, 3, 30.1.2024, date:3.2024, Seite 1184-1200 |
Published |
2024 |
Language |
|
Country |
|
Topic |
|
Subject |
Internal Medicine.
Oncology. Cardiology. Rheumatology.
Endocrinology.
Pharmacology. |
Persistent identifier |
urn:nbn:de:101:1-2404291050408.187346672817 (URN) |
Record ID |
1327826208 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: